Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas

This study has been completed.
Sponsor:
Information provided by:
BioCryst Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00035022
First received: May 2, 2002
Last updated: January 12, 2006
Last verified: February 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: March 2004
  Estimated Primary Completion Date: No date given